gemfibrozil 300 mg

mavacamten. amoxsan 500 mg gemfibrozil will increase the level or effect of mavacamten by affecting hepatic enzyme CYP2C19 metabolism Contraindicated Strong or moderate CYP2C19 inhibitors may increase mavacamten systemic exposure, resulting in heart failure due to systolic dysfunction ombitasvir/paritaprevir/ritonavir dasabuvir (DSC) gemfibrozil will